NCT07543471 2026-04-21
PK equivalence
Shanghai Henlius Biotech
Phase 1 Not yet recruiting
Clinical Trials
3 trialsNCT07116577 2025-08-11
Radiotherapy Combined QL1706, TAS-102 and Bevacizumab in mCRC
Jinan Central Hospital
Phase 2 Not yet recruiting
NCT03567629 2018-06-26
Evaluate the Efficacy of Irinotecan Versus Oxaliplatin in the First-line Treatment of Refractory Metastatic Colorectal Cancer
Peking University
Phase 2 Unknown